Cargando…

Clinical Significance and Systematic Expression Analysis of the Thyroid Receptor Interacting Protein 13 (TRIP13) as Human Gliomas Biomarker

SIMPLE SUMMARY: High expression of TRIP13 is associated with IDH-wild type gliomas. Patients with elevated TRIP13 levels are indicative of the poor survival outcome. The study aimed to provide comprehensive information about the oncogenic potential of TRIP13 in clinical significance for gliomas. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ssu-Han, Lin, Hong-Han, Li, Yao-Feng, Tsai, Wen-Chiuan, Hueng, Dueng-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150328/ https://www.ncbi.nlm.nih.gov/pubmed/34066132 http://dx.doi.org/10.3390/cancers13102338

Ejemplares similares

Shugoshin 2 is a biomarker for pathological grading and survival prediction in patients with gliomas
por: Kao, Ying, et al.
Publicado: (2021)

Proteolipid Protein 2 Overexpression Indicates Aggressive Tumor Behavior and Adverse Prognosis in Human Gliomas
por: Chen, Yi-Hsuan, et al.
Publicado: (2018)

DDX3X Biomarker Correlates with Poor Survival in Human Gliomas
por: Hueng, Dueng-Yuan, et al.
Publicado: (2015)

ARID4B Knockdown Suppresses PI3K/AKT Signaling and Induces Apoptosis in Human Glioma Cells
por: Luo, Siou-Min, et al.
Publicado: (2021)

Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas
por: Tsai, Wen-Chiuan, et al.
Publicado: (2016)

Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas
por: Tsai, Chia-Kuang, et al.
Publicado: (2018)

Disassembly of the Shieldin Complex by TRIP13
por: Sarangi, Prabha, et al.
Publicado: (2020)

Overexpression of TELO2 decreases survival in human high-grade gliomas
por: Feng, Shao-Wei, et al.
Publicado: (2016)

Decoding the prognostic significance of integrator complex subunit 9 (INTS9) in glioma: links to TP53 mutations, E2F signaling, and inflammatory microenvironments
por: Lin, Yu-Chieh, et al.
Publicado: (2023)

CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines
por: Li, Yao-Feng, et al.
Publicado: (2020)

Antiproliferative and apoptotic effects of telmisartan in human glioma cells
por: Chang, Yung-Lung, et al.
Publicado: (2023)

Ancient ubiquitous protein 1 (AUP1) is a prognostic biomarker connected with TP53 mutation and the inflamed microenvironments in glioma
por: Chang, Pei-Chi, et al.
Publicado: (2023)

Insights into a Crucial Role of TRIP13 in Human Cancer
por: Lu, S., et al.
Publicado: (2019)

Targeting TRIP13 for overcoming anticancer drug resistance (Review)
por: Zhao, Liwen, et al.
Publicado: (2023)

TRIP 13-dependent pathways promote the development of gastric cancer
por: Ni, Fengming, et al.
Publicado: (2023)

Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways
por: Lan, Jin, et al.
Publicado: (2022)

DNA damage is overcome by TRIP13 overexpression during cisplatin nephrotoxicity
por: Hama, Taketsugu, et al.
Publicado: (2021)

Osimertinib induces paraptosis and TRIP13 confers resistance in glioblastoma cells
por: Hu, Lulu, et al.
Publicado: (2023)

Midkine expression in high grade gliomas: Correlation of this novel marker with proliferation and survival in human gliomas
por: Cheng, Yen-Po, et al.
Publicado: (2014)

The Anti-Cancer Effect of Four Curcumin Analogues on Human Glioma Cells
por: Luo, Siou-Min, et al.
Publicado: (2021)

TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer
por: Sheng, Nengquan, et al.
Publicado: (2018)

Molecular mechanisms of assembly and TRIP13-mediated remodeling of the human Shieldin complex
por: Xie, Wei, et al.
Publicado: (2021)

Interstitial Control-Released Polymer Carrying a Targeting Small-Molecule Drug Reduces PD-L1 and MGMT Expression in Recurrent High-Grade Gliomas with TMZ Resistance
por: Liu, Ching-Ann, et al.
Publicado: (2022)

TRIP13 and APC15 drive mitotic exit by turnover of interphase- and unattached kinetochore-produced MCC
por: Kim, Dong Hyun, et al.
Publicado: (2018)

The mechanisms of malic enzyme 2 in the tumorigenesis of human gliomas
por: Cheng, Chiao-Pei, et al.
Publicado: (2016)

EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas
por: Tsai, Wen-Chiuan, et al.
Publicado: (2013)

Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
por: Zhu, Meng-Xuan, et al.
Publicado: (2019)

Mouse Pachytene Checkpoint 2 (Trip13) Is Required for Completing Meiotic Recombination but Not Synapsis
por: Li, Xin, et al.
Publicado: (2007)

TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma
por: Tao, Yi, et al.
Publicado: (2017)

The conserved AAA-ATPase PCH-2 (TRIP13) regulates spindle checkpoint strength
por: Défachelles, Lénaïg, et al.
Publicado: (2020)

Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway
por: Lu, Rujian, et al.
Publicado: (2021)

TRIP13/FLNA Complex Promotes Tumor Progression and Is Associated with Unfavorable Outcomes in Melanoma
por: Lu, Wang, et al.
Publicado: (2022)

TRIP13 localizes to synapsed chromosomes and functions as a dosage-sensitive regulator of meiosis
por: Chotiner, Jessica Y., et al.
Publicado: (2023)

TRIP13 overexpression in hepatocellular carcinoma: implications for poor prognosis and immune cell infiltration
por: Xue, Jiapeng, et al.
Publicado: (2023)

Potential of Neural Stem Cell-Based Therapy for Parkinson's Disease
por: Chou, Chung-Hsing, et al.
Publicado: (2015)

Correction to: Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
por: Zhu, Meng-Xuan, et al.
Publicado: (2019)

Thyroid Receptor-Interacting Protein 13 is Correlated with Progression and Poor Prognosis in Bladder Cancer
por: Niu, Lijuan, et al.
Publicado: (2019)

Correction: Mouse Pachytene Checkpoint 2 (Trip13) Is Required for Completing Meiotic Recombination but Not Synapsis
por: Chenglin Li, Xin, et al.
Publicado: (2007)

TRIP13 is a protein-remodeling AAA+ ATPase that catalyzes MAD2 conformation switching
por: Ye, Qiaozhen, et al.
Publicado: (2015)

Mechanistic insight into TRIP13-catalyzed Mad2 structural transition and spindle checkpoint silencing
por: Brulotte, Melissa L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hm4rota1lp6cnh96p7glgaoc8d